SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-129057
Filing Date
2021-04-23
Accepted
2021-04-23 16:26:05
Documents
14
Period of Report
2021-04-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d143358d8k.htm   iXBRL 8-K 34289
2 EX-99.1 d143358dex991.htm EX-99.1 15064
6 GRAPHIC g143358g0423200151924.jpg GRAPHIC 3040
  Complete submission text file 0001193125-21-129057.txt   189410

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20210423.xsd EX-101.SCH 3076
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20210423_lab.xml EX-101.LAB 18840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20210423_pre.xml EX-101.PRE 11843
7 EXTRACTED XBRL INSTANCE DOCUMENT d143358d8k_htm.xml XML 3535
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 21850127
SIC: 2834 Pharmaceutical Preparations